Transformative Diagnostics


Next-Generation Therapies & Vaccines

Addressing large, unmet global markets with innovative proprietary products More »


Worldwide Production & Distribution

Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »


Strategic Investments

Identifying early-stage companies with potential to increase value for shareholders More »

blank line

OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors.

News & Events

more news »

Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A Multinational, Multicenter Early Feasibility Trial of the TiaraTM Transcatheter Mitral Valve more »

OPKO Health Supports National Prostate Cancer Council Legislation more »

OPKO's Second Rayaldee Phase 3 Trial Meets Primary Endpoints more »


read more »

OPKO Health is an opportunistic research and development company that targets large, high-growth markets.